6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-methyl-, hydrobromide (1:1) structure
|
Common Name | 6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-methyl-, hydrobromide (1:1) | ||
---|---|---|---|---|
CAS Number | 59709-57-8 | Molecular Weight | 260.12800 | |
Density | N/A | Boiling Point | 362.6ºC at 760 mmHg | |
Molecular Formula | C10H14BrNO2 | Melting Point | 186-187ºC(lit.) | |
MSDS | Chinese USA | Flash Point | 175.4ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Name | 6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline hydrobromide |
---|---|
Synonym | More Synonyms |
Boiling Point | 362.6ºC at 760 mmHg |
---|---|
Melting Point | 186-187ºC(lit.) |
Molecular Formula | C10H14BrNO2 |
Molecular Weight | 260.12800 |
Flash Point | 175.4ºC |
Exact Mass | 259.02100 |
PSA | 52.49000 |
LogP | 2.59140 |
Appearance of Characters | white to brown |
Storage condition | Hygroscopic, -20?C Freezer, Under Inert Atmosphere |
Stability | Store in freezer at -20°C |
Water Solubility | H2O: soluble5mg/mL (warmed; clear solution) |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Hazard Codes | Xn |
Risk Phrases | R34 |
Safety Phrases | S25-S36/37/39-S45 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2933499090 |
~99% 6,7-Isoquinolin... CAS#:59709-57-8 |
Literature: Dalence-Guzman, Maria F.; Berglund, Magnus; Skogvall, Staffan; Sterner, Olov Bioorganic and Medicinal Chemistry, 2008 , vol. 16, # 5 p. 2499 - 2512 |
Precursor 1 | |
---|---|
DownStream 2 | |
HS Code | 2933499090 |
---|---|
Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
A trivalent approach for determining in vitro toxicology: Examination of oxime K027.
J. Appl. Toxicol. 35(2) , 219-27, (2014) Unforeseen toxic effects contribute to compound attrition during preclinical evaluation and clinical trials. Consequently, there is a need to correlate in vitro toxicity to in vivo and clinical outcom... |
1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol,hydrobromide |
MFCD00012741 |